| Project/Area Number |
24700977
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Tumor biology
|
|---|
| Research Institution | Osaka University (2013)
Kyoto University (2012) |
|---|
Principal Investigator |
AKAMATSU KANAKO 大阪大学, 医学(系)研究科(研究院), 研究員 (90553967)
|
|---|
| Project Period (FY) |
2012-04-01 – 2014-03-31
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2012: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | kinase inhibitor / combination dosage / molecular mechanism / combination drug / シグナル伝達 / 癌 / システム創薬 |
|---|
| Research Abstract |
I analyzed an anti-tumor mechanism through a variability analysis in vivo. In this study, I focused on two-species mixture drugs treatment; combination of two-species drugs has intense anti-tumor effect, whereas both drugs are ineffective in tumor suppression when it is used as a sole regimen. Through the about 30000 spices chemical assay, I discovered two candidate drugs, C053 and C127, which showed a drastic decrease in cell survivals. Although a structure activity correlation assay, and a variability analysis of C053 did not uncover a totally new apoptotic pathway, I found some combinations of established drug and C053 strongly induced apoptosis. This finding has a possibility for new drug discovery and medical applying for drug resistance caner cells.
|
